Can Eli Lilly and Company (LLY) Win Any Important Patent Lawsuit?  
8/22/2010 12:04:24 PM

Pharmalot -- Already one of the most vulnerable big drugmakers to patent expirations, Eli Lilly was dealt a serious blow late yesterday when a federal judge invalidated a method-of-use patent on its Strattera ADHD pill. The upshot means that a slew of generic pills from Teva Pharmaceutical and Sandoz, among others, are now expected to appear imminently, instead of in 2017.